Human hypocretin and melanin-concentrating hormone levels are linked to emotion and social interaction

Nature Communications

Volumn 4, Issue , 2013, Pages

  Blouin, Ashley M ^a,b   Fried, Itzhak ^a   Wilson, Charles L ^a,c   Staba, Richard J ^c   Behnke, Eric J ^a   Lam, Hoa A ^a   Maidment, Nigel T ^a   Karlsson, Karl Æ ^a,d   Lapierre, Jennifer L ^a   Siegel, Jerome M ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d REYKJAVIK UNIVERSITY   (Iceland)

^e VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MELANIN CONCENTRATING HORMONE; OREXIN;

HORMONE; MELANIN; NEUROLOGY; PEPTIDE; SOCIAL BEHAVIOR;

ADULT; AMYGDALOID NUCLEUS; ANGER; ANIMAL CELL; ANIMAL TISSUE; AROUSAL; ARTICLE; CONTROLLED STUDY; EATING; EMOTION; FEMALE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; MALE; NONHUMAN; POSTOPERATIVE PAIN; PROTEIN BLOOD LEVEL; RAT; SLEEP; SLEEP INDUCTION; SOCIAL INTERACTION; WAKEFULNESS;

ADULT; AMYGDALA; ANIMALS; BEHAVIOR; ELECTRODES, IMPLANTED; EMOTIONS; FEMALE; HUMANS; HYPOTHALAMIC HORMONES; HYPOTHALAMUS; INTERPERSONAL RELATIONS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MELANINS; MICRODIALYSIS; MIDDLE AGED; NEUROPEPTIDES; PITUITARY HORMONES; RATS; SLEEP; TIME FACTORS; WAKEFULNESS; YOUNG ADULT;

EID: 84875134387     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms2461     Document Type: Article

References (58)

1. Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat. Med. 6, 991-997 (2000).
2. Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469-474 (2000).
3. Liu, M. et al. Orexin gene transfer into zona incerta neurons suppresses muscle paralysis in narcoleptic mice. J. Neurosci. 31, 6028-6040 (2002).
4. Siegel, J. M. Hypocretin (orexin): role in normal behavior and neuropathology. Ann. Rev. Psychol. 55, 125-148 (2004).
5. McGregor, R., Wu, M.-F., Barber, G., Ramanathan, L. & Siegel, J. M. Highly specific role of hypocretin (orexin) neurons: differential activation as a function of diurnal phase, operant reinforcement versus operant avoidance and light level. J. Neurosci. 31, 15455-15467 (2011).
6. Wu, M. F., Nienhuis, R., Maidment, N., Lam, H. A. & Siegel, J. M. Role of the hypocretin (orexin) receptor 2 (Hcrt-r2) in the regulation of hypocretin level and cataplexy. J. Neurosci. 31, 6305-6310 (2011).
7. Anic-Labat, S. et al. Validation of a cataplexy questionnaire in 983 sleep-disorders patients. Sleep 22, 77-87 (1999). (Pubitemid 29097901)
8. White, E. C. & de Lahunta, A. Narcolepsy in a ram lamb. Vet. Rec. 149, 156-157 (2001). (Pubitemid 32729678)
9. Strain, G. M., Olcott, B. M., Archer, R. M. & McClintock, B. K. Narcolepsy in a Brahman bull. J. Am. Vet. Med. Assoc. 185, 538-541 (1984).
10. Willie, J. T. et al. Distinct narcolepsy syndromes in Orexin receptor-2 and Orexin null mice: molecular genetic dissection of Non-REM and REM sleep regulatory processes. Neuron 38, 715-730 (2003). (Pubitemid 36694779)
11. Mileykovskiy, B. Y., Kiyashchenko, L. I. & Siegel, J. M. Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron 46, 787-798 (2005). (Pubitemid 40733133)
12. Kiyashchenko, L. I. et al. Release of hypocretin (orexin) during waking and sleep states. J. Neurosci. 22, 5282-5286 (2002). (Pubitemid 35386448)
13. Lee, M. G., Hassani, O. K. & Jones, B. E. Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J. Neurosci. 25, 6716-6720 (2005). (Pubitemid 40995304)
14. Thannickal, T. C., Lai, Y. Y. & Siegel, J. M. Hypocretin (orexin) and melanin concentrating hormone loss and the symptoms of Parkinson's disease. Brain 131, e87 (2008).
15. Thannickal, T. C., Nienhuis, R. & Siegel, J. M. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy. Sleep 32, 993-998 (2009).
16. Lagos, P., Torterolo, P., Jantos, H., Chase, M. H. & Monti, J. M. Effects on sleep of melanin-concentrating hormone (MCH) microinjections into the dorsal raphe nucleus. Brain Res. 1265, 103-110 (2009).
17. Boissard, R., Fort, P., Gervasoni, D., Barbagli, B. & Luppi, P. H. Localization of the GABAergic and non-GABAergic neurons projecting to the sublaterodorsal nucleus and potentially gating paradoxical sleep onset. Eur. J. Neurosci. 18, 1627-1639 (2003). (Pubitemid 37215115)
18. Lagos, P., Monti, J. M., Jantos, H. & Torterolo, P. Microinjection of the melanin-concentrating hormone into the lateral basal forebrain increases REM sleep and reduces wakefulness in the rat. Life Sci. 90, 895-899 (2012).
19. De Lecea, L. et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc. Natl Acad. Sci. USA 95, 322-327 (1998). (Pubitemid 28103952)
20. Sakurai, T. et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92, 573-585 (1998). (Pubitemid 28101119)
21. Borgland, S. L. et al. Orexin A/hypocretin-1 selectively promotes motivation for positive reinforcers. J. Neurosci. 29, 11215-11225 (2009).
22. Sharf, R. et al. Orexin signaling via the orexin 1 receptor mediates operant responding for food reinforcement. Biol. Psychiatry 67, 753-760 (2010).
23. Wu, M. F., John, J., Maidment, N., Lam, H. A. & Siegel, J. M. Hypocretin release in normal and narcoleptic dogs after food and sleep deprivation, eating, and movement. Am. J. Physiol. Regul. Integr. Comp. Physiol. 283, R1079-R1086 (2002). (Pubitemid 35216982)
24. Wu, M. F., Nienhuis, R., Maidment, N., Lam, H. A. & Siegel, J. M. Cerebrospinal fluid hypocretin (orexin) levels are elevated by play but are not raised by exercise and its associated heart rate, blood pressure, respiration or body temperature changes. Arch. Ital. Biol. 149, 492-498 (2011).
25. Gulyani, S., Wu, M.-F., Nienhuis, R., John, J. & Siegel, J. M. Cataplexy-related neurons in the amygdala of the narcoleptic dog. Neuroscience 112, 355-365 (2002). (Pubitemid 34607019)
26. Khatami, R., Birkmann, S. & Bassetti, C. L. Amygdala dysfunction in narcolepsy-cataplexy. J. Sleep. Res. 16, 226-229 (2007). (Pubitemid 46850090)
27. Liu, X. et al. Antagonizing corticotropin-releasing factor in the central nucleus of the amygdala attenuates fear-induced reductions in sleep but not freezing. Sleep 34, 1539-1549 (2011).
28. Nofzinger, E. A. et al. Human regional cerebral glucose metabolism during non-rapid eye movement sleep in relation to waking. Brain 125, 1105-1115 (2002). (Pubitemid 34464621)
29. Siegel, J. M. et al. Neuronal degeneration in canine narcolepsy. J. Neurosci 19, 248-257 (1999). (Pubitemid 29028966)
30. van der, H. E. et al. REM sleep depotentiates amygdala activity to previous emotional experiences. Curr. Biol. 21, 2029-2032 (2011).
31. Espana, R. A., Reis, K. M., Valentino, R. J. & Berridge, C. W. Organization of hypocretin/orexin efferents to locus coeruleus and basal forebrain arousal-related structures. J. Comp. Neurol. 481, 160-178 (2005). (Pubitemid 39587437)
32. Lai, Y. Y., Kodama, T. & Siegel, J. M. Changes in monoamine release in the ventral horn and hypoglossal nucleus linked to pontine inhibition of muscle tone: an in vivo microdialysis study. J. Neurosci. 21, 7384-7391 (2001). (Pubitemid 32846985)
33. Brundin, L., Bjorkqvist, M., Traskman-Bendz, L. & Petersen, A. Increased orexin levels in the cerebrospinal fluid the first year after a suicide attempt. J Affect. Disord. 113, 179-182 (2009).
34. Henriques, J. B. & Davidson, R. J. Decreased responsiveness to reward in depression. Cogn. Emotion 14, 721-724 (2000).
35. Bayard, S. et al. Decision making in narcolepsy with cataplexy. Sleep 34, 99-104 (2011).
36. Thannickal, T. C. & Siegel, J. M. Hypocretin pathology in human narcolepsy. In Narcolepsy and Hypersomnia. (eds. Bassetti, C. L., Billiard, M. & Mignot, E.) 301-305 (Informa Healthcare, 2007).
37. Winrow, C. J. et al. Pharmacological characterization of MK-6096-a dual orexin receptor antagonist for insomnia. Neuropharmacology 62, 978-987 (2012).
38. Adamantidis, A. R., Zhang, F., Aravanis, A. M., Deisseroth, K. & de, L. L. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450, 420-424 (2007). (Pubitemid 350126754)
39. Siegel, J. M. The neurobiology of sleep. Semin. Neurol. 29, 277-296 (2009).
40. Wu, M. F. et al. Activity of dorsal raphe cells across the sleep-waking cycle and during cataplexy in narcoleptic dogs. J. Physiol. 554, 202-215 (2004).
41. Siegel, J. M. Behavioral functions of the reticular formation. Brain Res. Rev. 1, 69-105 (1979). (Pubitemid 9246025)
42. Dauvilliers, Y. et al. High pain frequency in narcolepsy with cataplexy. Sleep Med. 12, 572-577 (2002).
43. Hassani, O. K., Lee, M. G. & Jones, B. E. Melanin-concentrating hormone neurons discharge in a reciprocal manner to orexin neurons across the sleep-wake cycle. Proc. Natl Acad. Sci. USA 106, 2418-2422 (2009).
44. Modirrousta, M., Mainville, L. & Jones, B. E. Orexin and MCH neurons express c-Fos differently after sleep deprivation versus recovery and bear different adrenergic receptors. Eur. J. Neurosci. 21, 2807-2816 (2005). (Pubitemid 40835123)
45. Thannickal, T. C., Lai, Y. Y. & Siegel, J. M. Hypocretin (orexin) cell loss in Parkinson's disease. Brain 130, 1586-1595 (2007). (Pubitemid 47355933)
46. Funato, H. et al. Enhanced orexin receptor-2 signaling prevents diet-induced obesity and improves leptin sensitivity. Cell Metab. 9, 64-76 (2009).
47. Winsky-Sommerer, R., Boutrel, B. & de Lecea, L. Stress and arousal: the corticotrophin-releasing factor/hypocretin circuitry. Mol. Neurobiol. 32, 285-294 (2005). (Pubitemid 43024033)
48. Kiss, A. Immobilization induced fos expression in the medial and lateral hypothalamic areas: a limited response of hypocretin neurons. Ideggyogy. Sz. 60, 192-195 (2007).
49. Furlong, T. M., Vianna, D. M., Liu, L. & Carrive, P. Hypocretin/orexin contributes to the expression of some but not all forms of stress and arousal. Eur. J. Neurosci. 30, 1603-1614 (2009).
50. Johnson, P. L. et al. A key role for orexin in panic anxiety. Nat. Med. 16, 111-115 (2010).
51. Maidment, N. T. & Evans, C. J. Measurement of extracellular neuropeptides in the brain: Microdialysis linked to solid phase radioimmunoassays with subfemptomole limits of detection. In Microdialysis in the Neurosciences. (eds. Robinson, T. E. & Justice, J. B.) 275-303 (Elsevier, 1991).
52. Engel, J. Epilepsy surgery. Neurology 7, 140-147 (1994). (Pubitemid 24096874)
53. Cornford, E. M. et al. Regional analyses of CNS microdialysate glucose and lactate in seizure patients. Epilepsia 43, 1360-1371 (2002). (Pubitemid 35364994)
54. During, M. J., Fried, I., Leone, P., Katz, A. & Spencer, D. D. Direct measurement of extracellular lactate in the human hippocampus during spontaneous seizures. J. Neurochem. 62, 2356-2361 (1994). (Pubitemid 24179519)
55. Wilson, C. L. et al. Comparison of seizure related amino acid release in human epileptic hippocampus versus a chronic, kainate rat model of hippocampal epilepsy. Epilepsy Res. 26, 245-254 (1996). (Pubitemid 26420746)
56. Scheyer, R. D. et al. Phenytoin concentrations in the human brain: an in vivo microdialysis study. Epilepsy Res. 18, 227-232 (1994). (Pubitemid 24246934)
57. Fried, I. et al. Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J. Neurosurg. 91, 697-705 (1999). (Pubitemid 30133472)
58. Mai, J. K., Assheuer, J. & Paxinos, G. Atlas of the Human Brain (Elsevier Academic Press, 2004).